In this article, we will take a look at the 5 Best Brain-Computer Interface Stocks to Buy. For a deeper discussion and an extended list, please see the 10 Best Brain-Computer Interface Stocks to Buy.
Pixabay/Public Domain
5. Medtronic plc (NYSE:MDT)
Number of Hedge Fund Holders: 60
On June 8, Medtronic plc (NYSE:MDT) Chairman and CEO Geoffrey Martha said on Fox Business Network’s The Claman Countdown that the company now expects a $250 million tariff hit for fiscal 2027, down from a prior $300 million estimate due to supply chain adjustments. It includes $75 million in the first quarter.
Martha noted the figure could change given new US tariff threats targeting multiple trading partners emerge, saying, “we’ll have to re-evaluate that.”
He said tariffs remain “pretty meaningful,” surging year over year and adding pressure along with higher input costs such as fuel. He underlined that around 80% of Medtronic plc (NYSE:MDT)’s supply chain and over 90% of R&D are based in the US.
Martha pointed to growth as a buffer with a 78% revenue jump in cardiac ablation alongside strength in pacemakers, surgical, and spine businesses.
He also said the medtech firm put in $2 billion in acquisitions over the past fiscal year and invests $5 billion to $6 billion annually in innovation.
Medtronic plc (NYSE:MDT) is a medical technology company. It works in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit segments.
4. Abbott Laboratories (NYSE:ABT)
Number of Hedge Fund Holders: 73
Abbott Laboratories (NYSE:ABT) is among the Best Brain-Computer Interface Stocks.
On June 4, Reuters reported a federal judge ruled that Abbott Laboratories (NYSE:ABT) must face a proposed class-action lawsuit alleging it misled consumers by marketing PediaSure Grow & Gain drinks as “clinically proven” to help children grow.
US District Judge Paul Engelmayer said labeling featuring a giraffe and ruler-like marks could lead consumers to interpret “grow” as height gain, while “gain” implied weight. Hence, the claims will proceed, and Abbott Laboratories (NYSE:ABT) must defend.
In a 75-page decision, Engelmayer noted jurors could find the firm’s commercials reinforced that message, citing an ad showing a boy comparing himself to taller peers.
The corporation said its labeling is “appropriate” and backed by evidence, maintaining PediaSure supports children’s growth and development.
Plaintiff Joanne Noriega said her grandson remained short after a year of daily use but became overweight, while her lawyer James Denlea said he welcomed the ruling.
Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells healthcare products. It operates through Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices segments.
3. Apple Inc. (NASDAQ:AAPL)
Number of Hedge Fund Holders: 170
On June 18, Reuters reported that Apple Inc. (NASDAQ:AAPL) will permit developers in Brazil to distribute iOS apps through alternative marketplaces and use payment options outside its in-app system under an agreement with antitrust regulator CADE.
The company said developers using the App Store in Brazil can include alternative payment methods. It can also direct users to external websites to complete transactions, growing distribution and payment flexibility.
The tech giant said the shift introduces “new options for developers.” However, the corporation cautioned that alternative distribution and payment channels may elevate risks, including fraud, malware, scams, and privacy threats.
Separately, Apple Inc. (NASDAQ:AAPL) said it will apply safeguards such as app notarization, marketplace authorization, and protections for minors, given that Apps distributed outside the App Store will not receive the same level of review.
The firm pointed out that developers can adopt the changes immediately with iOS 26.5.
Apple Inc. (NASDAQ:AAPL) designs, manufactures, and sells smartphones, personal computers, tablets, wearables, and accessories, as well as a variety of connected services. It functions in the Americas, Europe, Greater China, Japan, and the Rest of the Asia Pacific.
2. Meta Platforms, Inc. (NASDAQ:META)
Number of Hedge Fund Holders: 262
Meta Platforms, Inc. (NASDAQ:META) is among the Best Brain-Computer Interface Stocks.
On June 22, Reuters reported that Meta Platforms, Inc. (NASDAQ:META) will pause its internal Model Capability Initiative program, which tracks employee mouse movements, clicks, and keystrokes for artificial intelligence training. The firm is investigating data security concerns.
While citing documents it reviewed, Reuters reported sensitive employee data collected through the program was accessible to all Meta staffers, prompting an employee to file a high-priority security incident report. The internal documentation showed exposed data included “full prompts and transcriptions, private conversations, people & performance data, DSS sensitivity ratings (1-4).”
Meta Platforms, Inc. (NASDAQ:META) spokesperson Tracy Clayton told Reuters the company had “no indication at this time that any data was improperly accessed.” He also said the program was designed with privacy safeguards and is being paused during the investigation.
Reuters said the Model Capability Initiative was launched in April and was still recording as of Monday afternoon, as per an undisclosed source.
Meta Platforms, Inc. (NASDAQ:META) specializes in the creation of social media applications. It develops technology that allows individuals to connect and share, discover communities, and grow businesses.
1. NVIDIA Corporation (NASDAQ:NVDA)
Number of Hedge Fund Holders: 275
NVIDIA Corporation (NASDAQ:NVDA) is among the Best Brain-Computer Interface Stocks.
On June 22, CNBC reported that NVIDIA Corporation (NASDAQ:NVDA) shares have underperformed in 2026. The firm rose about 12% compared with the VanEck Semiconductor ETF’s nearly 85% gain while slipping roughly 3% over the past month as investors are focusing on memory chips and infrastructure.
The report said growth in that segment has lifted companies such as Micron Technology and Sandisk, both up nearly 60% in the past month. Meanwhile, NVIDIA Corporation (NASDAQ:NVDA) “sat on the sidelines” during the rotation.
CNBC, citing Ornn data, reported the artificial intelligence chipmaker’s B200 compute price peaked at $6.11 per hour on May 30 before falling to $4.22 by June 21.
CNBC stated that Kalshi traders now expect prices to remain below that peak through June, showing softer demand projections.
Finance professor at Santa Clara University, Seoyoung Kim, told CNBC that uncertainty over future GPU demand and supply leaves both buyers and manufacturers, including Nvidia, unsure how much capacity to plan for.
NVIDIA Corporation (NASDAQ:NVDA) designs and manufactures computer graphics processors, chipsets, and related multimedia applications. It functions in two segments: graphics processing unit and compute and networking.
While we acknowledge the potential of NVDA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVDA and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
